🔗 Share this article

Treasury head Reeves has stated she is preparing "specific measures to tackle household expense issues" in the forthcoming Budget.

During an interview with the BBC, she stated that reducing inflation is a joint duty of both the government and the central bank.

The UK's price growth is forecast to be the most elevated among the Group of Seven advanced economies this year and next.

Potential Energy Cost Measures

Reports indicate the administration could intervene to bring down utility costs, for instance by slashing the present 5% level of value-added tax applied on energy supplies.

An additional approach is to reduce some of the government charges currently included in bills.

Fiscal Constraints and Expert Predictions

The administration will obtain the latest report from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will clarify how much room there is for such actions.

The view from most analysts is that Reeves will have to announce higher taxes or spending cuts in order to fulfill her declared fiscal targets.

Previously on the same day, analysis showed there was a £22 billion shortfall for the Treasury chief to address, which is at the lower end of projections.

"It is a collective responsibility between the Bank of England and the government to bear down further on some of the causes of price increases," the Chancellor stated to reporters in the US capital, at the annual meetings of the International Monetary Fund and World Bank.

Revenue Pledges and International Issues

While a great deal of the attention has been on probable tax increases, the Treasury chief said the most recent information from the OBR had not altered her vow to election pledges not to increase rates on earnings tax, sales tax or National Insurance.

She attributed an "unpredictable world" with growing international and trade issues for the fiscal tax moves, likely to be directed on those "wealthiest."

International Economic Disputes

Commenting on apprehensions about the UK's economic relations with the Asian nation she said: "Our national security invariably are paramount."

Recent declaration by Chinese authorities to increase trade restrictions on rare earths and other materials that are key for advanced tech production led US President the US President to threaten an extra 100% import tax on imports from the Asian country, increasing the risk of an full-scale trade war between the two global powers.

The American finance chief called the Chinese decision "commercial pressure" and "a international production power grab."

Questioned on accepting the American proposal to join its dispute with the Asian nation, Reeves said she was "deeply worried" by Chinese measures and called on the Beijing authorities "to avoid restrictions and limit trade."

She said the decision was "damaging for the international commerce and causes additional headwinds."

"It is my opinion there are sectors where we must address Chinese policies, but there are also important chances to export to Chinese markets, including banking sector and other areas of the economic system. We've got to achieve that balance right."

The chancellor also confirmed she was collaborating with other major economies "on our own critical minerals strategy, so that we are less reliant."

Health Service Drug Pricing and Funding

The Chancellor also acknowledged that the price the National Health Service spends on drugs could rise as a result of ongoing talks with the Trump administration and its drugs companies, in return for reduced taxes and investment.

Some of the world's largest pharmaceutical manufacturers have said recently that they are either delaying or scrapping projects in the United Kingdom, with some attributing the insufficient payments they are receiving.

Last month, the Science Minister said the cost the NHS spends on medicines would need to increase to prevent companies and pharmaceutical investment leaving the United Kingdom.

Reeves informed media: "We have seen as a result of the cost structure, that clinical trials, new drugs have not been offered in the United Kingdom in the extent that they are in other continental states."

"The objective is to make sure that patients getting treatment from the NHS are can access the best critical drugs in the globe. And so we are looking at all of that, and... seeking to secure additional funding into the UK."